1. Assessment of the 4‐factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study. Issue 5 (24th February 2021) Authors: Morabito, Fortunato; Tripepi, Giovanni; Del Poeta, Giovanni; Mauro, Francesca Romana; Reda, Gianluigi; Sportoletti, Paolo; Laurenti, Luca; Coscia, Marta; Herishanu, Yair; Varettoni, Marzia; Murru, Roberta; Chiarenza, Annalisa; Visentin, Andrea; Condoluci, Adalgisa; Moia, Riccardo; Pietrasanta, Da... Journal: American journal of hematology Issue: Volume 96:Issue 5(2021) Page Start: E168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparison of ibrutinib and idelalisib plus rituximab in real‐life relapsed/resistant chronic lymphocytic leukemia cases. (28th January 2021) Authors: Morabito, Fortunato; Tripepi, Giovanni; Del Poeta, Giovanni; Mauro, Francesca Romana; Reda, Gianluigi; Sportoletti, Paolo; Laurenti, Luca; Coscia, Marta; Herishanu, Yair; Bossio, Sabrina; Varettoni, Marzia; Murru, Roberta; Chiarenza, Annalisa; Visentin, Andrea; Condoluci, Adalgisa; Moia, Riccardo... Journal: European journal of haematology Issue: Volume 106:Number 4(2021) Page Start: 493 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real‐life campus CLL study. Issue 3 (21st December 2021) Authors: Visentin, Andrea; Mauro, Francesca Romana; Cibien, Francesca; Vitale, Candida; Reda, Gianluigi; Fresa, Alberto; Ciolli, Stefania; Pietrasanta, Daniela; Marchetti, Monia; Murru, Roberta; Gentile, Massimo; Rigolin, Gian Matteo; Quaglia, Francesca Maria; Scarfò, Lydia; Sportoletti, Paolo; Pravato, S... Journal: American journal of hematology Issue: Volume 97:Issue 3(2022) Page Start: E95 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effectiveness of ibrutinib as first‐line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab‐bendamustine: Results of study on 486 cases outside clinical trials. Issue 8 (3rd May 2021) Authors: Morabito, Fortunato; Tripepi, Giovanni; Del Poeta, Giovanni; Mauro, Francesca Romana; Reda, Gianluigi; Sportoletti, Paolo; Laurenti, Luca; Coscia, Marta; Herishanu, Yair; Bossio, Sabrina; Varettoni, Marzia; Murru, Roberta; Chiarenza, Annalisa; Visentin, Andrea; Condoluci, Adalgisa; Moia, Riccardo... Journal: American journal of hematology Issue: Volume 96:Issue 8(2021) Page Start: E269 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy of front‐line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter "Real‐World" study. Issue 2 (25th November 2022) Authors: Levi, Shai; Bronstein, Yotam; Goldschmidt, Neta; Morabito, Fortunato; Ziv‐Baran, Tomer; Del Poeta, Giovanni; Bairey, Osnat; Del Principe, Maria Ilaria; Fineman, Riva; Mauro, Francesca Romana; Gutwein, Odit; Reda, Gianluigi; Ruchlemer, Rosa; Sportoletti, Paolo; Laurenti, Luca; Shvidel, Lev; Coscia... Journal: American journal of hematology Issue: Volume 98:Issue 2(2023) Page Start: E24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group. Issue 3 (26th March 2021) Authors: Rigolin, Gian Matteo; Cavazzini, Francesco; Piciocchi, Alfonso; Arena, Valentina; Visentin, Andrea; Reda, Gianluigi; Zamprogna, Giulia; Cibien, Francesca; Vitagliano, Orsola; Coscia, Marta; Farina, Lucia; Gaidano, Gianluca; Murru, Roberta; Varettoni, Marzia; Paolini, Rossella; Sportoletti, Paolo;... Journal: Hematological oncology Issue: Volume 39:Issue 3(2021) Page Start: 326 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Management of chronic lymphocytic leukemia in Italy during a one year of the COVID‐19 pandemic and at the start of the vaccination program. A Campus CLL report. Issue 4 (13th July 2021) Authors: Cuneo, Antonio; Rigolin, Gian Matteo; Coscia, Marta; Quaresmini, Giulia; Scarfò, Lydia; Mauro, Francesca Romana; Motta, Marina; Quaglia, Francesca Maria; Trentin, Livio; Ferrario, Andrea; Laurenti, Luca; Reda, Gianluigi; Ferrari, Angela; Pietrasanta, Daniela; Sportoletti, Paolo; Re, Francesca; De... Journal: Hematological oncology Issue: Volume 39:Issue 4(2021) Page Start: 570 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. TP53 disruption as a risk factor in the era of targeted therapies: A multicenter retrospective study of 525 chronic lymphocytic leukemia cases. Issue 8 (25th May 2021) Authors: Morabito, Fortunato; Del Poeta, Giovanni; Mauro, Francesca Romana; Reda, Gianluigi; Sportoletti, Paolo; Laurenti, Luca; Coscia, Marta; Herishanu, Yair; Bossio, Sabrina; Varettoni, Marzia; Murru, Roberta; Chiarenza, Annalisa; Visentin, Andrea; Condoluci, Adalgisa; Moia, Riccardo; Pietrasanta, Dani... Journal: American journal of hematology Issue: Volume 96:Issue 8(2021) Page Start: E306 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗